Macquarie Group Ltd. increased its position in shares of Walgreens Boots Alliance Inc (NASDAQ:WBA) by 3.4% during the second quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 53,510 shares of the pharmacy operator’s stock after buying an additional 1,740 shares during the quarter. Macquarie Group Ltd.’s holdings in Walgreens Boots Alliance were worth $3,211,000 as of its most recent SEC filing.

A number of other large investors have also recently added to or reduced their stakes in WBA. Massachusetts Financial Services Co. MA purchased a new position in Walgreens Boots Alliance during the 2nd quarter worth approximately $199,228,000. FIL Ltd grew its stake in Walgreens Boots Alliance by 1,062.9% during the 1st quarter. FIL Ltd now owns 2,711,135 shares of the pharmacy operator’s stock worth $177,499,000 after buying an additional 2,478,006 shares during the last quarter. Caisse DE Depot ET Placement DU Quebec grew its stake in Walgreens Boots Alliance by 32.1% during the 1st quarter. Caisse DE Depot ET Placement DU Quebec now owns 9,966,798 shares of the pharmacy operator’s stock worth $652,526,000 after buying an additional 2,419,053 shares during the last quarter. LSV Asset Management grew its stake in Walgreens Boots Alliance by 17.2% during the 2nd quarter. LSV Asset Management now owns 8,704,233 shares of the pharmacy operator’s stock worth $522,384,000 after buying an additional 1,277,546 shares during the last quarter. Finally, Burgundy Asset Management Ltd. grew its stake in Walgreens Boots Alliance by 16.0% during the 2nd quarter. Burgundy Asset Management Ltd. now owns 7,161,408 shares of the pharmacy operator’s stock worth $429,792,000 after buying an additional 986,275 shares during the last quarter. Hedge funds and other institutional investors own 61.92% of the company’s stock.

A number of research analysts recently issued reports on the company. BidaskClub upgraded Walgreens Boots Alliance from a “buy” rating to a “strong-buy” rating in a research note on Friday. Zacks Investment Research upgraded Walgreens Boots Alliance from a “hold” rating to a “buy” rating and set a $81.00 target price on the stock in a research note on Tuesday. ValuEngine upgraded Walgreens Boots Alliance from a “strong sell” rating to a “sell” rating in a research note on Friday, September 21st. TheStreet upgraded Walgreens Boots Alliance from a “c+” rating to a “b” rating in a research note on Wednesday, September 12th. Finally, Robert W. Baird lifted their target price on Walgreens Boots Alliance from $64.00 to $69.00 and gave the company a “neutral” rating in a research note on Tuesday, September 11th. Two equities research analysts have rated the stock with a sell rating, eleven have given a hold rating, six have given a buy rating and two have assigned a strong buy rating to the company’s stock. The company has a consensus rating of “Hold” and a consensus price target of $77.11.

In other news, COO Ornella Barra acquired 1,700,000 shares of Walgreens Boots Alliance stock in a transaction that occurred on Monday, July 16th. The stock was purchased at an average cost of $65.15 per share, with a total value of $110,755,000.00. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director William C. Foote sold 2,736 shares of Walgreens Boots Alliance stock in a transaction on Thursday, August 2nd. The stock was sold at an average price of $65.99, for a total value of $180,548.64. Following the transaction, the director now directly owns 10,943 shares of the company’s stock, valued at $722,128.57. The disclosure for this sale can be found here. 14.80% of the stock is owned by company insiders.

WBA opened at $73.81 on Friday. The company has a quick ratio of 0.47, a current ratio of 0.93 and a debt-to-equity ratio of 0.44. The company has a market capitalization of $71.66 billion, a PE ratio of 14.47, a price-to-earnings-growth ratio of 1.10 and a beta of 1.09. Walgreens Boots Alliance Inc has a 12 month low of $59.07 and a 12 month high of $80.68.

Walgreens Boots Alliance (NASDAQ:WBA) last posted its quarterly earnings results on Thursday, June 28th. The pharmacy operator reported $1.53 EPS for the quarter, beating the consensus estimate of $1.47 by $0.06. The business had revenue of $34.33 billion during the quarter, compared to analysts’ expectations of $34.15 billion. Walgreens Boots Alliance had a return on equity of 21.22% and a net margin of 3.36%. The company’s quarterly revenue was up 14.0% compared to the same quarter last year. During the same period last year, the firm earned $1.33 EPS. research analysts forecast that Walgreens Boots Alliance Inc will post 5.97 EPS for the current fiscal year.

About Walgreens Boots Alliance

Walgreens Boots Alliance, Inc operates as a pharmacy-led health and wellbeing company. It operates through three segments: Retail Pharmacy USA, Retail Pharmacy International, and Pharmaceutical Wholesale. The Retail Pharmacy USA segment sells prescription drugs and an assortment of general merchandise, including non-prescription drugs, beauty products, photo finishing, seasonal merchandise, greeting cards, and convenience foods through its retail drugstores and convenient care clinics.

Read More: What does the Dow Jones Industrial Average (DJIA) measure?

Institutional Ownership by Quarter for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.